HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,261,938 | -43.2% | 313,136 | -90.0% | 0.68% | -38.0% |
| Q2 2023 | $2,223,285 | -4.6% | 3,131,388 | 0.0% | 1.09% | +12.3% |
| Q1 2023 | $2,329,753 | +2.5% | 3,131,388 | 0.0% | 0.97% | +2.1% |
| Q4 2022 | $2,273,388 | -25.1% | 3,131,388 | 0.0% | 0.95% | -17.8% |
| Q3 2022 | $3,037,000 | -49.2% | 3,131,388 | 0.0% | 1.16% | -54.2% |
| Q2 2022 | $5,981,000 | -61.6% | 3,131,388 | 0.0% | 2.52% | -52.5% |
| Q1 2022 | $15,563,000 | -34.2% | 3,131,388 | 0.0% | 5.32% | +4.1% |
| Q4 2021 | $23,642,000 | -4.4% | 3,131,388 | 0.0% | 5.11% | -10.9% |
| Q3 2021 | $24,738,000 | -43.0% | 3,131,388 | +0.0% | 5.73% | -29.0% |
| Q2 2021 | $43,417,000 | -35.9% | 3,130,267 | -3.3% | 8.07% | -38.3% |
| Q1 2021 | $67,745,000 | -9.9% | 3,238,306 | -28.4% | 13.09% | +23.1% |
| Q4 2020 | $75,151,000 | -2.2% | 4,524,425 | 0.0% | 10.64% | -25.8% |
| Q3 2020 | $76,870,000 | +2.4% | 4,524,425 | 0.0% | 14.33% | -35.9% |
| Q2 2020 | $75,105,000 | +43.3% | 4,524,425 | 0.0% | 22.35% | -29.9% |
| Q1 2020 | $52,393,000 | -21.7% | 4,524,425 | 0.0% | 31.87% | +8.2% |
| Q4 2019 | $66,916,000 | +8.3% | 4,524,425 | 0.0% | 29.45% | +11.4% |
| Q3 2019 | $61,804,000 | +5.1% | 4,524,425 | 0.0% | 26.45% | +11.3% |
| Q2 2019 | $58,818,000 | +37.3% | 4,524,425 | 0.0% | 23.77% | +34.5% |
| Q1 2019 | $42,846,000 | – | 4,524,425 | – | 17.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |